Used as a key intermediate in the synthesis of kinase inhibitors, particularly in pharmaceutical research targeting cancer therapies. Its structure enables selective binding to specific enzyme sites, making it valuable in developing drugs that regulate cell signaling pathways. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies due to its ability to enhance potency and metabolic stability in lead compounds. Also utilized in the development of targeted therapies for oncology, where it contributes to the inhibition of abnormal protein kinases involved in tumor growth.